---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-223985"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2026-05-14T20:06:06+00:00"
generated_at: "2026-05-14T21:01:21.435848+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Arcadia Q1 net loss $4.4M ($2.11/share); Zola volumes +18% YoY

## Summary
- Net loss attributable to common stockholders $4.385M (EPS -$2.11) vs net income $2.599M ($1.90 EPS) in Q1 2025.
- Zola coconut water unit volume +18% YoY; total revenue $1.1M down 8% due to $193k revenue reserve release in prior year.
- SG&A $1.179M, lowest in public company history, down $559k YoY; cash and equivalents $0.954M vs $0.259M at year-end.
- January 2026 warrant inducement generated $2.1M gross proceeds but caused $2.877M loss; company continues evaluating strategic alternatives.
- Company plans new product launch fall 2026; Zola benefited from price increase at start of year.

## SEC filing metadata
- accession: 0001193125-26-223985
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2026-05-14T20:06:06+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000119312526223985/0001193125-26-223985-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000119312526223985/rkda-20260514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-223985
- JSON: https://secwatch.observer/filing/0001193125-26-223985.json
- Plain text: https://secwatch.observer/filing/0001193125-26-223985.txt

## Key facts
- Earnings Releases
  Arcadia Biosciences, Inc. reported financial results for first quarter of 2026.
  - Period: first quarter of 2026
  - Result: reported results
  source text: On May 14, 2026 Arcadia Biosciences, Inc. (the “Company”) issued a press release announcing financial results for the first quarter of 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1469443/000119312526223985/0001193125-26-223985-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.